光宇生醫發表生物醫學研究級PCL-石墨烯與PCL-氧化石墨烯3D列印線材 光宇生醫客製化線材服務再揭新里程碑。光宇生醫今日宣布可提供PCL-石墨烯與PCL-氧化石墨烯之3D列印線材之客製化線材服務。石墨烯在近幾年的應用越來越為廣泛，除了工業方面的應用外，研究學者也積極探索石墨烯在生物醫學領域方面的應用。本公司已成功開發出生物可降解材料PCL與石墨烯混合之特殊製程，可穩定提供PCL-石墨烯(0.5%)與PCL-氧化石墨烯(0.5%)列印線給客戶，預期將有助於研究學者探討更多石墨烯在生物醫學領域之潛力與可能性。若對石墨烯列印線有需求之客戶，歡迎聯絡我們。 光宇生醫提供客製化特殊線材服務，專門替客戶客製化特殊材料，提供小量(50g起跳)與彈性之製造服務，歡迎客戶來信洽詢。
Advanced Biomedical Technology Inc. launch PCL-graphene and PCL-graphene oxide 3D printing filament for biomedical research. Advanced Biomedical Technology Inc. (ABT) today announced that it can offer new 3D printing filaments, PCL-graphene filament and PCL-graphene oxide filament. Graphene has been used more and more widely in recent years. In addition to industrial applications, researchers
Business Adjustments due to COVID-19 Pandemic Advanced Biomedical Technology Inc. announced today that it has determined temporary stop all customization services business. The filament business is still in operation, clients who would like to order MeDFila®, please Contact us.
During the COVID 19 pandemic, we hope everyone will be good. During the hard condition we met, we still keep our RD activity and collect the hottest data from the animal study with our materials and printing system. After 3 month implantation, here we show the promising neotissue growth within our AM BONE GRAFT
光宇生醫科技獲外媒評選為2019年亞太區10大新創生技企業。
Advanced Biomedical Technology awarded Taiwan Government Grant (FY2019-2020)
Advanced Biomedical Technology Inc., the first company in Taiwan, receives the FDA-announced Device Master File registering for biodegradable 3D-printing materials.
光宇生醫科技：公告本公司收到美國fda通知，本公
Advanced Biomedical Technology Inc, (ABT) announced that its office in Hsinchu Biomedical Park, which was first opened in 2016, has now relocated to a larger facility in the Hsinchu Science Park. The new headquarters office of Advanced Biomedical Technology in Hsinchu, Taiwan Bruce Chen, CEO of ABT said “As a medical grade biodegradable
